Scott M Coiante
CIK 1608536 · SVP, Chief Financial Officer · last filed 2026-03-03
Scott M Coiante is a SVP, Chief Financial Officer who has filed 21 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for LXRX, was dated Mar 3, 2026. Across all open-market trades the lifetime net is +$37.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $389.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$389.2K
3
21
$37.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LXRX | SVP, Chief Financial Officer | 160,237 | $2.40 | $384.6K | $0 | 4 | 2026-03-03 |
| AGILE THERAPEUTICS INC (AGRX) Delisted | Chief Financial Officer | 20,080 | $1.51 | $30.3K | $0 | 8 | 2023-10-04 |
| APRE | SVP, Chief Financial Officer | 7,253 | $0.64 | $4.7K | $37.5K | 8 | 2022-08-01 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-03 | LXRX | Mixed | +105,356 | -$80.7K | EDGAR |
| 2026-02-17 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2025-02-18 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2025-01-02 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2024-08-26 | — | Disp (D) | −20,080 | -$30.5K | |
| 2023-10-04 | AGILE THERAPEUTICS INC (AGRX) Delisted | Grant (A) | +20,000 | $0 | EDGAR |
| 2022-08-01 | APRE | Grant (A) | +60,800 | $0 | EDGAR |
| 2022-06-07 | APRE | Tax (F) | −35,284 | -$28.4K | EDGAR |
| 2022-03-14 | APRE | Grant (A) | +42,900 | $0 | EDGAR |
| 2022-03-01 | APRE | Tax (F) | −14,817 | -$25.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.